Highland Marketing has been looking ahead to 2024 and asking health tech leaders what they expect to see in health tech this year. The chair of the advisory board, Jeremy Nettle, argues that with a general election approaching, the NHS needs a period of stability to address the pressures it is facing.

Antibodies are an important tool in the human immune system's arsenal against disease. They attach to bacteria, viruses, fungi, or toxins, marking them for destruction or removal from the body.

It is this ability to recognise and mark foreign and harmful molecules and organisms that allows therapeutic use of antibodies, including treating or preventing diseases such as cancer, as well as auto-immune and metabolic diseases.

The state of NHS infrastructure and legacy systems has started to attract attention from organisations worried about falling productivity. The Highland Marketing advisory board asked what it will take to fix the issues, against a backdrop of more funding being diverted from digital to "the frontline."

The NHS is heading for a significant financial squeeze, with its already tight 2021 Budget settlement eroded by inflation and the bill for a year of strikes - which has come in at around £1 billion.

The agreement with NHS National Services Scotland (NSS) will provide tools that will support healthcare teams as they review and report on around 5 million radiology examinations a year, working across NHS Scotland organisations.

The fully managed software as a service (SaaS), Sectra One Cloud, will be used by all of Scotland's 14 territorial NHS boards and by NHS Golden Jubilee, which also hosts the Scottish National Radiology Reporting Service.

NEJM Group, publisher of the New England Journal of Medicine, today announced the launch of its newest title, NEJM AI, a peer-reviewed, monthly journal dedicated to the latest research and application of artificial intelligence (AI) and machine learning in medicine. In addition to original research articles, the journal publishes reviews, policy perspectives and educational material for clinicians, scientists, health care leaders, policy makers, regulators, and executives with pharmaceutical, device-manufacturing and technology companies.

Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their healthy aging journey. The partnership elevates the shared aspiration of both companies to transform self-care by offering precision health solutions to enable consumers to better understand and make informed decisions about their own personal health and lifestyle choices.

Ebenbuild, a company developing personalized, AI-driven virtual lungs to support clinical decisions and digital clinical trials, announced its participation in the research project Personalized Lung Twins for the Treatment of Acute Respiratory Distress Syndrome (UBIC) in collaboration with the University Hospital Schleswig-Holstein, Augsburg University Hospital, University Hospital Carl Gustav Carus Dresden, University Hospital RWTH Aachen and University Medical Center Mannheim.